Codex Launches 8 Products to Combat COVID-19

Suite of products and services designed to accelerate the development of solutions to combat COVID-19

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Codex DNA, Inc. has developed and released suite of products and services designed to accelerate the development of solutions to combat COVID-19. The company has also released a SARS-CoV-2 application note that details how to leverage the BioXp 3200 system to help advance the fight against COVID-19, and announced the availability of eight new products:  Codex SARS-CoV-2 diagnostic RNA controls – safe and robust positive controls that replace the need for live virus in RT-PCR and NGS...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters